Market Cap ₹458 Cr.
Stock P/E 28.9
P/B 2.1
Current Price ₹49.6
Book Value ₹ 23.4
Face Value 2
52W High ₹78.5
Dividend Yield 0%
52W Low ₹ 47.7
Nova Agritech Limited is a research-based company that produces and sells agri inputs such as bio stimulants, micronutrients and organic inputs. The company was established in 2007 and has manufacturing facilities in Hyderabad. The company’s vision is to be a global leader in provision of comprehensive agriculture technology solutions while balancing the goals between food security and environment sustainability. The company’s mission is to provide a wide range of cutting edge agriput solutions through continued and organized research and focus towards quality and excellence, ultimately leading to an ecologically sustainable, nutritionally balanced and financially profitable farming community. The company also has a vibrant R&D department that has led to the production of vital substitute products and cost-effective agrochemicals on a large scale and consequently to a strong, competitive national and international presence.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Dec 2023 |
|---|---|---|
| Net Sales | 56 | 78 |
| Other Income | 0 | 0 |
| Total Income | 56 | 78 |
| Total Expenditure | 45 | 63 |
| Operating Profit | 10 | 15 |
| Interest | 2 | 2 |
| Depreciation | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 |
| Profit Before Tax | 8 | 12 |
| Provision for Tax | 2 | 3 |
| Profit After Tax | 6 | 10 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 6 | 10 |
| Adjusted Earnings Per Share | 0.2 | 1.5 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 116 | 131 | 127 | 161 | 186 | 211 | 134 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 116 | 131 | 127 | 161 | 186 | 211 | 134 |
| Total Expenditure | 100 | 118 | 113 | 142 | 158 | 172 | 108 |
| Operating Profit | 15 | 13 | 14 | 18 | 28 | 39 | 25 |
| Interest | 3 | 4 | 6 | 8 | 7 | 9 | 4 |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 7 | 5 | 9 | 18 | 28 | 20 |
| Provision for Tax | 3 | 3 | 2 | 2 | 5 | 8 | 5 |
| Profit After Tax | 6 | 5 | 3 | 6 | 14 | 20 | 16 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 6 | 5 | 3 | 6 | 14 | 20 | 16 |
| Adjusted Earnings Per Share | 1 | 0.8 | 0.5 | 1 | 2.2 | 3.3 | 1.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 18% | 13% | 0% |
| Operating Profit CAGR | 39% | 41% | 21% | 0% |
| PAT CAGR | 43% | 88% | 27% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 38% | 33% | 27% | 27% |
| ROCE Average | 31% | 27% | 24% | 24% |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 22 | 27 | 23 | 29 | 43 | 64 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 5 | 6 | 15 | 18 | 24 | 16 |
| Other Non-Current Liabilities | 1 | 3 | 1 | 1 | -3 | -3 |
| Total Current Liabilities | 69 | 82 | 89 | 95 | 92 | 99 |
| Total Liabilities | 97 | 118 | 128 | 144 | 156 | 176 |
| Fixed Assets | 15 | 17 | 16 | 17 | 18 | 17 |
| Other Non-Current Assets | 4 | 3 | 1 | 1 | 1 | 1 |
| Total Current Assets | 77 | 99 | 111 | 126 | 137 | 158 |
| Total Assets | 97 | 118 | 128 | 144 | 156 | 176 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 |
| Cash Flow from Operating Activities | 3 | 3 | -9 | 5 | 2 | 5 |
| Cash Flow from Investing Activities | -6 | -3 | -1 | -3 | -4 | -2 |
| Cash Flow from Financing Activities | 3 | -1 | 10 | -2 | 3 | -2 |
| Net Cash Inflow / Outflow | -0 | 0 | -0 | 0 | 1 | 2 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 3 |
| # | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.02 | 0.78 | 0.48 | 1 | 2.18 | 3.27 |
| CEPS(Rs) | 1.42 | 1.15 | 0.85 | 1.35 | 2.54 | 3.64 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 3.51 | 4.29 | 3.65 | 4.69 | 6.89 | 10.19 |
| Core EBITDA Margin(%) | 13.15 | 10.14 | 10.74 | 11.31 | 15.01 | 18.5 |
| EBIT Margin(%) | 11.06 | 8.37 | 8.91 | 10.15 | 13.82 | 17.56 |
| Pre Tax Margin(%) | 8.39 | 5.68 | 3.84 | 5.4 | 9.94 | 13.38 |
| PAT Margin (%) | 5.53 | 3.74 | 2.35 | 3.92 | 7.38 | 9.73 |
| Cash Profit Margin (%) | 7.69 | 5.52 | 4.2 | 5.26 | 8.57 | 10.85 |
| ROA(%) | 6.6 | 4.54 | 2.65 | 4.63 | 9.13 | 12.33 |
| ROE(%) | 29.04 | 19.98 | 13.27 | 24.08 | 37.7 | 38.27 |
| ROCE(%) | 24.55 | 19.97 | 18.64 | 21.82 | 27.29 | 30.51 |
| Receivable days | 132.15 | 137.84 | 163.25 | 177.67 | 174.99 | 172.19 |
| Inventory Days | 107.78 | 101.92 | 103 | 82.65 | 71.01 | 68.06 |
| Payable days | 206.85 | 212.57 | 220.03 | 167.58 | 126.74 | 89.88 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.37 | 0.33 | 0.46 | 0.39 | 0.4 | 0.38 |
| EV/Core EBITDA(x) | 2.77 | 3.23 | 4.3 | 3.43 | 2.7 | 2.04 |
| Net Sales Growth(%) | 0 | 13.06 | 9.5 | 26.83 | 15.53 | 13.45 |
| EBIT Growth(%) | 0 | -14.42 | -11.79 | 44.51 | 57.32 | 44.09 |
| PAT Growth(%) | 0 | -23.57 | -53.4 | 111.44 | 117.29 | 49.68 |
| EPS Growth(%) | 0 | -23.57 | -39.03 | 111.44 | 117.29 | 49.67 |
| Debt/Equity(x) | 1.37 | 1.14 | 2.01 | 1.74 | 1.49 | 1.11 |
| Current Ratio(x) | 1.12 | 1.2 | 1.25 | 1.32 | 1.5 | 1.6 |
| Quick Ratio(x) | 0.63 | 0.73 | 0.83 | 0.95 | 1.09 | 1.18 |
| Interest Cover(x) | 4.14 | 3.12 | 1.76 | 2.14 | 3.56 | 4.2 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2018 | Mar 2024 |
|---|---|---|
| Promoter | 82.13 | 59.39 |
| FII | 0 | 4.72 |
| DII | 0 | 3.27 |
| Public | 17.87 | 32.63 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Mar 2018 | Mar 2024 |
|---|---|---|
| Promoter | 1.03 | 5.49 |
| FII | 0 | 0.44 |
| DII | 0 | 0.3 |
| Public | 0.22 | 3.02 |
| Others | 0 | 0 |
| Total | 1.25 | 9.25 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
